The Madison company, Cellular Dynamics, which was founded by stem cell pioneer and University of Wisconsin-Madison scientist, James Thomson in 2004, has an exclusive license agreement with a New York medical school to turn stem cells into heart cells.

The license will allow Cellular Dynamics to manufacture cardiac cells from stem cells and provide them to pharmaceutical and biotech companies that test the toxicity of drugs.

According to Cellular Dynamics the license will cover a key patent portfolio that will allow the company to make cardiac cells such as cardiomyocytes, endothelial cells and vascular smooth muscle cells and could make available those cells to pharmaceutical and biotech companies working on testing the live saving cardiac drugs.

The University of Wisconsin-Madison scientist are famous for important stem cell discoveries, they were the first to isolate human embryonic stem cells in 1998.

Cellular Dynamics, known as CDI, initially is involved in selling stem cell-derived heart cells to Roche and other pharmaceutical companies to help them test the toxicity of drugs.

Now they are looking forward to industrialize production of human cell types for research and create a bio bank in which people could store stem cells engineered from their DNA for use in personalized therapies or in testing reactions to drugs.

Source: Capital Times